HIV prevalence has recently begun to decline in Zimbabwe, a result of both high levels of AIDS mortality and a reduction in incident infections. An important component in understanding the dynamics in HIV prevalence is knowledge of past trends in incidence, such as when incidence peaked and at what level. However, empirical measurements of incidence over an extended time period are not available from Zimbabwe or elsewhere in sub-Saharan Africa. Using mortality data, we use a back-calculation technique to reconstruct historic trends in incidence. From AIDS mortality data, extracted from death registration in Harare, together with an estimate of survival post-infection, HIV incidence trends were reconstructed that would give rise to the observed patterns of AIDS mortality. Models were fitted assuming three parametric forms of the incidence curve and under nine different assumptions regarding combinations of trends in non-AIDS mortality and patterns of survival post-infection with HIV. HIV prevalence was forward-projected from the fitted incidence and mortality curves. Models that constrained the incidence pattern to a cubic spline function were flexible and produced well-fitting, realistic patterns of incidence. In models assuming constant levels of non-AIDS mortality, annual incidence peaked between 4 and 5% between 1988 and 1990. Under other assumptions the peak level ranged from 3 to 8% per annum. However, scenarios assuming increasing levels of non-AIDS mortality resulted in implausibly low estimates of peak prevalence (11%), whereas models with decreasing underlying crude mortality could be consistent with the prevalence and mortality data. HIV incidence is most likely to have peaked in Harare between 1988 and 1990, which may have preceded the peak elsewhere in Zimbabwe. This finding, considered alongside the timing and location of HIV prevention activities, will give insight into the decline of HIV prevalence in Zimbabwe.
References
[1]
UNAIDS (2005) Evidence for HIV decline in Zimbabwe: a comprehensive review of the epidemiological data.
[2]
Gregson S, Nyamukapa CA, Garnett GP, Wambe M, Lewis JJ, et al. (2005) HIV infection and reproductive health in teenage women orphaned and made vulnerable by AIDS in Zimbabwe. AIDS Care 17: 785–94.
[3]
Anderson RM, May RM, Boily MC, Garnett GP, Rowley JT (1991) The spread of HIV-1 in Africa: sexual contact patterns and the predicted demographic impact of AIDS. Nature 352: 581–9.
[4]
Wasserheit JN, Aral SO (1996) The dynamic topology of sexually transmitted disease epidemics: implications for prevention strategies. J Infect Dis 174 Suppl 2: 201–13.
[5]
Mbizvo MT, Latif AS, Machekano R, MacFarland W, Bassett MT, et al. (1997) HIV seroconversion among factory workers in Harare: who is getting newly infected? Cent Afr J Med 43: 135–9.
[6]
Gregson S, Machekano R, Donnelly CA, Mbizvo MT, Anderson RM, Katzenstein DA (1998) Estimating HIV incidence from age-specific prevalence data: comparison with concurrent cohort estimates in a study of male factory workers, Harare, Zimbabwe. Aids 12: 2049–58.
[7]
Machekano R, McFarland W, Mbizvo MT, Bassett MT, Katzenstein D, Latif AS (1998) Impact of HIV counselling and testing on HIV seroconversion and reported STD incidence among male factory workers in Harare, Zimbabwe. Cent Afr J Med 44: 98–102.
[8]
Brookmeyer R, Gail MH (1994) Back-calculation. AIDS Epidemiology: A quantitative approach. New York: Oxford University Press. pp.
[9]
Isham V (1989) Estimation of the incidence of HIV infection. Philos Trans R Soc Lond B Biol Sci 325: 113–21.
[10]
Brookmeyer R (1991) Reconstruction and future trends of the AIDS epidemic in the United States. Science 253: 37–42.
[11]
United Nations Population Division (2004) Population Database. http://esa.un.org/unpp/.
[12]
Morgan D, Mahe C, Mayanja B, Okongo JM, Lubega R, Whitworth JA (2002) HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? Aids 16: 597–603.
[13]
CASCASE collaboration. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet 355: 1131–7.
[14]
Todd J, Glynn JR, Marston M, Lutalo T, Biraro S, et al. (2007) Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy. AIDS 21: S55–S63.
[15]
O'Sullivan F (Statistical Science) A statistical perspective on ill-posed inverse problems. Statistical Science 1: 502–527.
[16]
Motulksky H, Christopoulos A (2004) Generating confidence intervals via model comparison. Fitting models to biological data using linear and nonlinear regression. Oxford: OUP.
[17]
UNAIDS, Zimbabwe Ministry of Health and Child Welfare (2005) Zimbabwe National HIV/AIDS Estimates.
[18]
UNAIDS (2004) Report on the global AIDS epidemic.
[19]
Gregson S, Garnett GP, Nyamukapa CA, Hallett TB, Lewis JJ, et al. (2006) HIV decline associated with behavior change in eastern Zimbabwe. Science 311: 664–6.
[20]
Potts DH, Mutambirwa CC (1990) Rural-urban linkages in contemporary Harare: why migrants need their land. Journal of Southern African Studies 16: 177–198.
[21]
Howden D (2006) 3,500 dead each week as meltdown looms. The Independent; 8–9.
[22]
Feeney G (2001) The impact of HIV/AIDS on adult mortality in Zimbabwe. Population and Development Review 27: 10.
[23]
United Nations Population Division (2005) World Population Prospects: The 2004 Revision.
[24]
Measure DHS, Zimbabwe Central Statistical Office (2006) Zimbabwe Demographic and Health Survey: 2005–2006, Preliminary Report.
[25]
Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, Shearer S (2004) HIV and pulmonary tuberculosis: the impact goes beyond those infected with HIV. Aids 18: 657–62.
[26]
Abu-Raddad LJ, Patnaik P, Kublin JG (2006) Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 314: 1603–6.
[27]
Mbizvo MT, Kasule J, Mahomed K, Nathoo K (2001) HIV-1 seroconversion incidence following pregnancy and delivery among women seronegative at recruitment in Harare, Zimbabwe. Central African Journal of Medicine 47: 115–118.
